Cite
HARVARD Citation
Haduong, J. et al. (2022). An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials. Pediatric blood & cancer. 69 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Haduong, J. et al. (2022). An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials. Pediatric blood & cancer. 69 (4), p. n/a. [Online].